Article
ALS/FTLD-Linked Mutations in FUS Glycine Residues Cause Accelerated Gelation and Reduced Interactions with Wild-Type FUS.
Molecular cell - 19 Nov 2020
Rhine Kevin, Makurath Monika A, Liu James, Skanchy Sophie, Lopez Christian, Catalan Kevin F, Ma Ye, Fare Charlotte M, Shorter James, Ha Taekjip, Chemla Yann R, Myong Sua
Abstract excerpt
The RNA-binding protein fused in sarcoma (FUS) can form pathogenic inclusions in neurodegenerative diseases like amyotrophic lateral sclerosis (ALS) and frontotemporal lobar dementia (FTLD). Over 70 mutations in Fus are linked to ALS/FTLD. In patients, all Fus mutations are heterozygous, indicating that the mutant drives disease progression despite the presence of wild-type (WT) FUS. Here, we demonstrate that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
